BOSTON SCIENTIFIC CORPORATION vs Intuitive Surgical, Inc., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BSX and ISRG diverge most: on debt / equity, BSX reads 0.50 and ISRG reads 0.00; on p/s, BSX reads 3.00 and ISRG reads 13.73. The rest of the comparable metrics sit closer together. What BSX's price implies is a bet that sits within the historical range (whole-company basis). What ISRG's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BSX | ISRG |
|---|---|---|
| Price | $42.74 | $423.92 |
| Market cap | $63.0B | $151.5B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Growth |
| Implied growth (priced in) | +1.6% | — |
| P/E | 17.3 | 48.7 |
| P/B | 2.50 | 8.28 |
| P/S | 3.00 | 13.73 |
| EV/EBITDA | 13.8 | 42.6 |
| Revenue growth | +13.8% | +20.8% |
| Gross margin | 70.7% | 67.8% |
| Operating margin | 21.6% | 33.6% |
| Net margin | 17.5% | 28.4% |
| Return on equity | 14.6% | 17.1% |
| Return on assets | 8.1% | 15.0% |
| Return on invested capital | 9.4% | 14.7% |
| FCF yield | 5.8% | 2.1% |
| Debt / equity | 0.50 | 0.00 |
| Current ratio | 1.24 | 4.96 |
| Altman Z (solvency) | 6.83 | 7.58 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.